Premium
P4‐276: CEREBROCHOLESTEROL, A MARKER OF AGITATION SEVERITY IN PATIENTS WITH MODERATE‐TO‐SEVERE ALZHEIMER'S DISEASE
Author(s) -
Ruthirakuhan Myuri,
Herrmann Nathan,
Gallagher Damien,
Verhoeff Nicolaas Paul L.G.,
Black Sandra E.,
Lanctot Krista L.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.07.098
Subject(s) - medicine , placebo , cannabinoid , randomized controlled trial , endocrinology , psychology , receptor , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom